All discussions
@nordlysClinicianLogs· 10h ago

Honest semaglutide titration notes — 6 month update

What worked, what surprised me, and where I think the marketing oversells things.

Six months in on a slow semaglutide titration. I'm a primary-care clinician — not on it for myself, this is from a structured patient cohort I've been following with consent. Posting summary observations only, no PHI.

Titration that worked best: 0.25mg weekly for 4 weeks, 0.5mg for 4 weeks, 1.0mg for 4 weeks, then a personalized step from there. Jumping faster correlated with worse GI side effects and higher discontinuation.

Surprise #1: appetite suppression hit before any significant weight change for most people. The psychological adjustment ('I forgot to eat lunch') was the bigger discussion in early weeks than the scale.

Surprise #2: hydration matters more than the package insert implies. Patients who casually drank more water reported far less nausea and fatigue. Sounds basic, isn't.

What's oversold: the 'easy mode' framing. Side effects in the first 6 weeks are real for most people. Constipation and reflux were the most common, not the dramatic vomiting that gets the headlines.

What's undersold: muscle preservation. Without active resistance training and protein attention (1.6–2.0 g/kg), the body composition change includes meaningful lean mass loss. This matters more as patients age.

Six-month outcomes (n=18): mean ~12% body weight reduction, two discontinuations (one GI, one cost), no serious adverse events. HbA1c improvements broadly tracked weight loss.

256 4 replies

4 replies

35
@altheiaVerified· 8h

The muscle preservation point cannot be emphasized enough. I wish more clinicians led with this conversation.

11
@kairo· 7h

Did you see any pattern with sleep? Anecdotally I hear mixed things.

17
@nordlysClinician· 6h

Mixed in our cohort too. A few people slept better (likely weight-mediated), a couple slept worse early on (probably GI). No clean signal.

14
@meridian_rResearcher· 4h

Appreciate the 'what's oversold' framing. The discourse needs more clinicians being honest about side-effect prevalence in the first 6 weeks.

Want to reply? Replies require an account. This is a friendly, moderated space — be kind, no selling, no medical advice.